Utility of Decision Support Tools and Identification of Influential Factors in Treatment Selection for Early-Stage Non-Small Cell Lung Cancer

Utility of Decision Support Tools and Identification of Influential Factors in Treatment Selection for Early-Stage Non-Small Cell Lung Cancer - Utility of Decision Support Tools and Identification of Influential Factors in Treatment Selection for Early-Stage Non-Small Cell Lung Cancer

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000052599

Enrollment

Registered

2023-10-24

Start date

2023-10-24

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

non-small cell lung cancer

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Patients with a confirmed diagnosis of non-small cell lung cancer or those with a strong clinical suspicion. Patients with clinical stage cT1N0M0 or cT2N0M0. Patients eligible for both surgical treatment and SBRT for lung cancer. Patients aged 18 or older. Gender is not a consideration.

Exclusion criteria

Exclusion criteria: Patients who cannot appropriately utilize the treatment decision-making guide. Patients who have already determined their treatment plan. Other patients deemed ineligible by the primary physician.

Design outcomes

Primary

Measure	Time frame
The primary outcome is the 'survey results regarding the decision-making guide for early-stage lung cancer patients'	—

Countries

Japan

Contacts

Public ContactNobuaki Kobayashi

Yokohama City University Graduate School of Medicine Department of Pulmonology

nkobayas@yokohama-cu.ac.jp045-787-2800

Outcome results